November 6, 2023 12:02 PMJustices Grant Purdue Creditors Separate Argument Time
Try our Advanced Search for more refined results
By Jeff Overley and Ben Jay
Opioid crisis lawsuits against major companies in the pharmaceutical supply chain are heating up in large numbers, producing a byzantine brew of battles in courts all across America. Here, Law360 provides a map that will continue to track completed, ongoing and upcoming trials.
By Emlyn Cameron
Rite Aid Corp. asked a New Jersey bankruptcy judge to issue an injunction blocking the federal government from litigating a whistleblower suit in Ohio over the filling of illegal opioid prescriptions until the bankruptcy court can approve a reorganization plan.
By Shane Dilworth
Walmart's insurers urged an Arkansas state judge to find they have no duty to defend the retail giant against suits brought over the opioid epidemic, arguing that addiction and death tied to the powerful prescription pain medications do not constitute accidents covered under their policies.
By Mike Curley
The Sixth Circuit on Tuesday refused to compel the disqualification of a special master appointed to manage cases against pharmacy benefits managers in the national opioid multidistrict litigation over an email he inadvertently sent to all parties, saying nothing in the email shows bias.
By Alex Wittenberg
The U.S. Supreme Court will allow creditors of Purdue Pharma LP to make their own oral arguments in a case that asks whether the U.S. Bankruptcy Code authorizes as part of a Chapter 11 plan the release of third-party claims against members of the Sackler family.
By Dan McKay
The U.S. Supreme Court denied a petition Monday from an Alabama opioid prescriber who asked the justices to review whether lower courts have ignored the tougher prosecution standard established in his own Supreme Court case.
By J.B. Heaton
The Sixth Circuit was correct to find that intense pressure to settle doesn't earn opioid case defendants Walgreens and Walmart an interlocutory appeal or new trial on liability, as that argument applies only when a defendant is risk averse, a notion not suited to large public corporations, says J.B. Heaton at One Hat Research.
By Jeb White
Notwithstanding the misleadingly rosy picture painted by the U.S. Department of Justice’s fiscal year 2021 False Claims Act recovery statistics, Congress should close legislative gaps that deter whistleblower actions, especially in light of increasingly high government spending and adjacent opportunities to misuse public funds, says Jeb White at Taxpayers Against Fraud.
By Suzanne Jaffe Bloom, Benjamin Sokoly and Jack Cartwright
Attorneys at Winston unpack the recently released U.S. Department of Justice False Claims Act recovery statistics for fiscal year 2021, discuss how they compare to prior years and what companies in an expanding array of industries should expect next.
November 6, 2023 02:35 PMJustices Rebuff Opioid Doctor's Quest For 2nd Round
November 6, 2023 08:37 PMNC Judiciary Will Back Opioid Crisis-Driven Drug Court Study
October 31, 2023 06:12 PM6th Circ. Asked To Step Into Opioid Special Master Row
October 25, 2023 08:36 PMFirst Nations Group Asks High Court To Nix Sackler Releases
October 18, 2023 06:35 PMDrug Wholesaler Scores $10M Coverage Win For Opioid Suits
October 13, 2023 09:40 PMDOJ Inks Settlement With Fla. Doc In Fentanyl Kickback Case
October 11, 2023 07:57 PMBass Berry Establishes Team For Drug Policy Compliance
October 10, 2023 04:54 PMEmail Flub In Opioid MDL No Basis For Master's Removal
October 4, 2023 06:51 PMInsurer Fights Discovery Bid In $625M Opioid Coverage Row
September 28, 2023 08:06 PMOpioid Special Master's Email Doesn't Betray Bias, Court Told
September 21, 2023 01:24 PMTenn. AG Inks $44.5M Opioid Deal With Grocery Chain
September 21, 2023 07:34 PMOpioid MDL Special Master Fights Bias DQ For 'Email Mistake'
September 21, 2023 05:58 PMHartford Unit Scores 11th Circ. Win In Opioid Coverage Row
September 19, 2023 01:33 PM11th Circ. Skeptical Of Opioid Maker's Notice Arguments
September 18, 2023 04:34 PMExcess Insurers Prevail In Publix Opioid Suit, For Now
September 15, 2023 02:52 PMOpioid Maker Faces Uphill Coverage Battle Before 11th Circ.
September 12, 2023 07:21 PMOpioid Sales Fell By Half After 2010, DEA Data Shows
September 12, 2023 02:31 PM6th Circ. Asks Ohio Justices To Settle $650M Opioid Question
September 8, 2023 09:32 AMKroger To Pay Up To $1.4B To End Opioid Claims